EG14767A - Process for preparing of 2-substituted-trans-5-aryl-2,3,4,4a,5-9b-hexahydro-1h-pyrido(4,3-b)indoles - Google Patents

Process for preparing of 2-substituted-trans-5-aryl-2,3,4,4a,5-9b-hexahydro-1h-pyrido(4,3-b)indoles

Info

Publication number
EG14767A
EG14767A EG668/79D EG66879D EG14767A EG 14767 A EG14767 A EG 14767A EG 668/79 D EG668/79 D EG 668/79D EG 66879 D EG66879 D EG 66879D EG 14767 A EG14767 A EG 14767A
Authority
EG
Egypt
Prior art keywords
indoles
pyrido
hexahydro
trans
aryl
Prior art date
Application number
EG668/79D
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG14767A publication Critical patent/EG14767A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
EG668/79D 1979-01-23 1979-11-19 Process for preparing of 2-substituted-trans-5-aryl-2,3,4,4a,5-9b-hexahydro-1h-pyrido(4,3-b)indoles EG14767A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (1)

Publication Number Publication Date
EG14767A true EG14767A (en) 1985-12-31

Family

ID=21717248

Family Applications (1)

Application Number Title Priority Date Filing Date
EG668/79D EG14767A (en) 1979-01-23 1979-11-19 Process for preparing of 2-substituted-trans-5-aryl-2,3,4,4a,5-9b-hexahydro-1h-pyrido(4,3-b)indoles

Country Status (34)

Country Link
US (1) US4224329A (ko)
JP (4) JPS55100386A (ko)
KR (1) KR830001932A (ko)
AR (1) AR231291A1 (ko)
AT (1) AT376674B (ko)
AU (1) AU521986B2 (ko)
BE (1) BE881283A (ko)
CA (1) CA1144168A (ko)
CH (2) CH651040A5 (ko)
CS (4) CS221809B2 (ko)
DD (2) DD149071A5 (ko)
DE (1) DE3002367A1 (ko)
DK (1) DK25580A (ko)
EG (1) EG14767A (ko)
FI (1) FI800179A (ko)
FR (3) FR2447379A1 (ko)
GB (1) GB2041925B (ko)
GR (1) GR73567B (ko)
HU (3) HU184712B (ko)
IE (1) IE49500B1 (ko)
IL (1) IL59189A (ko)
IN (1) IN153300B (ko)
IT (1) IT1149927B (ko)
LU (1) LU82105A1 (ko)
NL (1) NL8000385A (ko)
NO (2) NO151895C (ko)
NZ (3) NZ197582A (ko)
PH (4) PH15736A (ko)
PL (4) PL120774B1 (ko)
PT (1) PT70724A (ko)
SE (3) SE441358B (ko)
SU (3) SU1168094A3 (ko)
YU (2) YU269379A (ko)
ZA (1) ZA796374B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (ko) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
SE8404555L (sv) 1984-09-11
SE8404555D0 (sv) 1984-09-11
SE441358B (sv) 1985-09-30
DD149071A5 (de) 1981-06-24
ATA33380A (de) 1984-05-15
NZ197582A (en) 1984-05-31
BE881283A (fr) 1980-07-22
IL59189A0 (en) 1980-05-30
SU1168094A3 (ru) 1985-07-15
SE8404554L (sv) 1984-09-11
AU5476580A (en) 1980-07-31
AU521986B2 (en) 1982-05-13
CS221806B2 (en) 1983-04-29
LU82105A1 (fr) 1980-08-08
SE8404554D0 (sv) 1984-09-11
CS221807B2 (en) 1983-04-29
NO794317L (no) 1980-07-24
PL126867B1 (en) 1983-09-30
IT1149927B (it) 1986-12-10
NZ192175A (en) 1984-05-31
NO843041L (no) 1980-07-24
JPS5636486A (en) 1981-04-09
IL59189A (en) 1984-01-31
JPS5636487A (en) 1981-04-09
YU242183A (en) 1984-06-30
JPS5636475A (en) 1981-04-09
PT70724A (en) 1980-02-01
CS221809B2 (en) 1983-04-29
NO151895C (no) 1985-06-26
ZA796374B (en) 1980-11-26
FI800179A (fi) 1980-07-24
IT8019373A0 (it) 1980-01-22
PH17773A (en) 1984-12-11
PL126532B1 (en) 1983-08-31
FR2447379B1 (ko) 1983-08-19
FR2453174A1 (fr) 1980-10-31
CH651040A5 (fr) 1985-08-30
CA1144168A (en) 1983-04-05
PL120774B1 (en) 1982-03-31
SU1333239A3 (ru) 1987-08-23
JPS5855151B2 (ja) 1983-12-08
GR73567B (ko) 1984-03-16
GB2041925B (en) 1982-10-20
SU1080746A3 (ru) 1984-03-15
CH648314A5 (fr) 1985-03-15
PH15736A (en) 1983-03-18
YU269379A (en) 1984-04-30
CS221808B2 (en) 1983-04-29
JPS5740151B2 (ko) 1982-08-25
DK25580A (da) 1980-07-24
JPS55100386A (en) 1980-07-31
NZ197581A (en) 1984-05-31
IE800121L (en) 1980-07-23
HU189174B (en) 1986-06-30
FR2447379A1 (fr) 1980-08-22
NO151895B (no) 1985-03-18
PL126032B1 (en) 1983-07-30
HU184712B (en) 1984-10-29
SE8000329L (sv) 1980-07-24
PH15072A (en) 1982-06-03
DD156369A5 (de) 1982-08-18
GB2041925A (en) 1980-09-17
PL221248A1 (ko) 1980-12-01
NL8000385A (nl) 1980-07-25
FR2453174B1 (ko) 1983-07-29
DE3002367A1 (de) 1980-07-24
IN153300B (ko) 1984-06-30
AR231291A1 (es) 1984-10-31
HU188201B (en) 1986-03-28
AT376674B (de) 1984-12-27
KR830001932A (ko) 1983-05-19
IE49500B1 (en) 1985-10-16
FR2453175A1 (fr) 1980-10-31
PH15086A (en) 1982-07-02
US4224329A (en) 1980-09-23
FR2453175B1 (ko) 1983-07-29

Similar Documents

Publication Publication Date Title
PT70914A (en) Process for preparing indole derivatives
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
EG14767A (en) Process for preparing of 2-substituted-trans-5-aryl-2,3,4,4a,5-9b-hexahydro-1h-pyrido(4,3-b)indoles
YU201080A (en) Process for preparing 3-aminopropoxyaryl derivatives of indole
YU6280A (en) Process for preparing new pleuromutiline derivatives
PL245404A1 (en) Process for preparing novel derivatives of 1,4:3,6-dianhydrohexites
PT71952B (en) Process for preparing 3,6,7,8-substituted-s-triazolo-^4,3-b[- pyridazines
HU187782B (en) Process for preparing trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-/4,3-b/indole derivatives
PL241179A1 (en) Process for preparing novel derivatives of 4a,9b-trans-hexahydro-1h-pyridoindole
PT72176A (en) Process for preparing 2,3-indoledione derivatives
PT71328A (en) Process for preparing new hydroxyamino-eburnane derivatives
YU44524B (en) Process for obtaining derivatives of 3,4-dihydro-2h-benzopyrans
YU278580A (en) Process for preparing new derivatives of 1-oxadethiacephalosporin
PL238085A1 (en) Process for preparing novel derivatives of 1,2,2-triphenylpropene
YU41953B (en) Process for obtaining new derivatives of 1-xo-1h-thizolo (3,2-a) pyrimidine-2-carboxamides
YU163779A (en) Process for obtaining imidazolyl-ethoxy derivatives of pyrrazolo (3,4-b)-pyridine-5-methanol
HU178523B (en) Process for preparing new pyrazolo-quinazoline derivatives
YU41639B (en) Process for preparing 5,8 dihydrofuro (3,2-b) 1,8 naphthirridine compounds
IL64147A (en) Process for preparing derivatives of 5,6,7,7a-tetrahydro-4h-thieno(3,2-c)pyridin-2-one
PT71056A (en) Process for preparing substituted 2-aminopirazines
PT70695A (en) Process for preparing new phenanthroline derivatives
PL249639A1 (en) Process for preparing novel derivatives,of 8-carbonylamino-4-aryl-2-methyl-1,2,3,4-tetrahydroisoquinoline
YU42530B (en) Process for preparing new 3-amino-2-oxo -oxazalidine derivatives
HU179621B (en) Process for preparing carbamete derivatives of mercapto-acyl-hydroxy-l-proline
HU178004B (en) Process for preparing new encephaline derivatives